Summary
- Current Price
- As of today, SLS price is $8.90, up +3.73% in the most recent trading session on
- Current Price All-Time High
- SLS price is currently -100.00% below its historical high of $718,500.00 set on
- Market Cap
- SLS current market cap is $2B, up +832.24% over the past 365 days
- PE Ratio
- SLS PE ratio is unknown
- Revenue
- SLS current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for SLS is on
Profile
| Metric | Value |
|---|---|
| Full Name | SELLAS Life Sciences Group, Inc. |
| Ticker | NASDAQ: SLS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | sellaslifesciences.com |
| Employees | 15 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $8.90 | |
| Price, 1D Change | +3.73% | |
| $2B | ||
| - | ||
| - | ||
| 1.72 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.25 | ||
| EPS, 1Y Change | +51.19% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:50 | |
| Next Split | N/A | N/A |
| Last Ticker Change | GALE | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.25 | ||
| EPS Estimate | N/A | -$0.21 |
| EPS Est. Change | N/A | +14.74% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $8.90 | |
| Price Target | - | $10.00 |
| Price Tgt. Change | - | +12.36% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.54 | -$0.50 | +5.98% | |
| -$0.26 | -$0.25 | +5.27% | |
| -$0.21 | N/A | +14.74% | |
| -$0.15 | N/A | +39.10% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $44.25M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $8.90 | |
| $3.39 | ||
| SMA 200 vs Price | -61.95% | |
| $5.41 | ||
| SMA 50 vs Price | -39.19% | |
| 1.72 | ||
| $0.73 | ||
| 69.28 | ||
| 181.69% | ||
| 94.78% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.25 | ||
| $0.00 | ||
| - | ||
| -$28.27M | ||
| - | ||
| -$26.86M | ||
| - | ||
| -$28.27M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 10.72 | ||
| 10.72 | ||
| - | ||
| - | ||
| 127.86 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 15.41 | ||
| -49.24 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $70.87M | ||
| $71.89M | ||
| $78.35M | ||
| $75.21M | ||
| $7.47M | ||
| $7.02M | ||
| $1.00M | ||
| $544.00K | ||
| $2.95M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $26.86M | ||
| $28.27M | ||
| $0.00 | ||
| $12.25M | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$28.39M | ||
| $0.00 | ||
| $86.30M | ||
| $0.00 | ||
| -$28.39M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Maxim Group | → | |
| Maxim Group | → | |
| Cantor Fitzgerald | → | |
| Cantor Fitzgerald | → | |
| Alliance Global Partners | ||
| Cantor Fitzgerald | ||
| Cantor Fitzgerald | ||
| Oppenheimer | ||
| Maxim Group | → | |
| H.C. Wainwright |
Analyst sentiment
Institutional ownership
Screeners with SLS
FAQ
What is the ticker symbol for SELLAS Life Sciences Group, Inc.?
The ticker symbol for SELLAS Life Sciences Group, Inc. is NASDAQ:SLS
Does SELLAS Life Sciences Group, Inc. pay dividends?
No, SELLAS Life Sciences Group, Inc. does not pay dividends
What sector is SELLAS Life Sciences Group, Inc. in?
SELLAS Life Sciences Group, Inc. is in the Healthcare sector
What industry is SELLAS Life Sciences Group, Inc. in?
SELLAS Life Sciences Group, Inc. is in the Biotechnology industry
What country is SELLAS Life Sciences Group, Inc. based in?
SELLAS Life Sciences Group, Inc. is headquartered in United States
When did SELLAS Life Sciences Group, Inc. go public?
SELLAS Life Sciences Group, Inc. initial public offering (IPO) was on March 12, 2008
Is SELLAS Life Sciences Group, Inc. in the S&P 500?
No, SELLAS Life Sciences Group, Inc. is not included in the S&P 500 index
Is SELLAS Life Sciences Group, Inc. in the NASDAQ 100?
No, SELLAS Life Sciences Group, Inc. is not included in the NASDAQ 100 index
Is SELLAS Life Sciences Group, Inc. in the Dow Jones?
No, SELLAS Life Sciences Group, Inc. is not included in the Dow Jones index
When was SELLAS Life Sciences Group, Inc. last earnings report?
SELLAS Life Sciences Group, Inc.'s most recent earnings report was on May 12, 2026
When does SELLAS Life Sciences Group, Inc. report earnings?
The next expected earnings date for SELLAS Life Sciences Group, Inc. is August 11, 2026
Data Sources & References
- SLS Official Website www.sellaslifesciences.com
- SLS Profile on Yahoo Finance finance.yahoo.com/quote/SLS
- SLS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sls